Antiapoptotic marker, Bcl-X(L), expression on Reed-Sternberg cells of Hodgkin's disease using a novel monoclonal marker, YTH-2H12

Human Pathology

Volumn 30, Issue 9, 1999, Pages 1065-1070

  Chu, Wei Sing ^a   Aguilera, Nadine S I ^a   Wei, Min Qi ^a   Abbondanzo, Susan L ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

Apoptosis; Bcl X(L) Hodgkin's disease; Reed Sternberg cells

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL SURVIVAL; EPSTEIN BARR VIRUS; GENE EXPRESSION; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; REED STERNBERG CELL; TISSUE DIFFERENTIATION;

EID: 0032888332     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90224-1     Document Type: Article

References (34)

1. Kroemer G: The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 3:614-620, 1997
2. Schlaifer D, March M, Krajewski S, et al: High expression of the bcl-x gene in Reed-Sternberg cells of Hodgkin's disease. Blood 85:2671-2674, 1995
3. L) in human lymphomas. Br J Haematol 92:900-906, 1996
4. Hsu YT, Youle RJ: Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272:13829-13834, 1997
5. L, during apoptosis. Biochemistry 94:3668-3672, 1997
6. Chu WS, Abbondanzo SL, Frizzera G: Inconsistency of the immunophenotype of Reed-Sternberg cells in simultaneous and consecutive specimens from the same patients. Am J Pathol 141:11-17, 1992
7. Vasef MA, Alsabeh R, MedeirosJ, et al: Immunophenotype of Reed-Sternberg and Hodgkin's cells in sequential biopsy specimens of Hodgkin's disease. Am J Clin Pathol 108:54-59, 1997
8. Pallesen G, Hamilton-Dutoit SJ, Rowe M, et al: Expression of Epstein-Barr virus latent gene products in tumor cells of Hodgkin's disease. Lancet 1:320-322, 1991
9. Hunyady B, Krempels K, Harta G, et al: Immunohistochemical signal amplification by catalyzed reporter deposition and its application in double immunostaining. J Histochem Cytochem 44:1353-1362, 1996
10. Wolter KG, Hsu YT, Smith CL, et al: Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281-1292, 1997
11. Leoncini L, Del Vecchio MT, Spina D, et al: Presence of the bcl-2 protein and apoptosis in non-Hodgkin lymphomas with diffuse growth pattern. Int J Cancer 61:826-831, 1995
12. Leoncini L, Del Vecchio MT, Megha T, et al: Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 142:755-763, 1993
13. Spina D, Leoncini L, Del Vecchio MT, et al: Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol 177:335-341, 1995
14. Surh CD, Sprent J: T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 372:100-103, 1994
15. Ueda N, Shah SV: Apoptosis. J Lab Clin Med 124:169-177, 1994
16. Schlaifer D, Rrajewski S, Galoin S, et al: Immunodetection of apoptosis-regulating proteins in lymphomas from patients with and without human immunodeficiency virus infection. Am J Pathol 149:177-185, 1996
17. Krajewski S, Krajewska M, Shabaik A, et al: Immunohistochemical analysis of in vivo patterns of Bcl-X expression. Cancer Res 54:5501-5507, 1994
18. Drexler HG: Recent results on the biology of Hodgkin and Reed-Sternberg cells I biopsy material. Leuk Lymphoma 8:283-313, 1992
19. Frizzera G: The distinction of Hodgkin's disease from anaplastic large cell lymphoma. Semin Diagn Pathol 9:291-296, 1992
20. Stein H: Ki-1 anaplastic large cell lymphoma: Is it a discrete entity? Leuk Lymphoma 10:81-84, 1993 (suppl)
21. Carbone A, Gloghini A, Volpe R: Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas. Virchows Arch A Pathol Anat Histopathol 420:527-532, 1992
22. Chittal SM, Caveriviere P, Schwarting R, et al: Monoclonal antibodies in the diagnosis of Hodgkin's disease: The search for a rational panel. Am J Surg Pathol 12:9-21, 1988
23. Brousset P, Benharroch D, Krajewski S, et al: Frequent expression of the cell death-inducing gene Bax in Reed-Sternberg cells of Hodgkin's disease. Blood 87:2470-2475, 1996
24. Lorenzen J, Thiele J, Fischer R: The mummified Hodgkin cell: Cell death in Hodgkin's disease. J Pathol 82:288-298, 1997
25. Reynolds DJ, Banks PM, Gulley ML: New characterization of infectious mononucleosis and a phenotypic comparison with Hodgkin's disease. Am J Pathol 146:379-388, 1995
26. Razzouk BI, Srinivas S, Sample CE, et al: Epstein-Barr virus DNA recombination and loss in sporadic Burkitt's lymphoma. J Infect Dis 173:529-535, 1996
27. Wang D, Liebowitz D, Wang F, et al: Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J Virol 62:4713-4784, 1988
28. Henderson S, Rowe M, Gregory C, et al: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1114, 1991
29. Jiwa NM, Oudejans JJ, Bai MC, et al: Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF-1 in Hodgkin's disease: implications for different pathogenic mechanisms. Histopathology 26:547-553, 1995
30. Abbondanzo SL, Sato N, Straus SE, et al: Acute infectious mononucleosis CD30 (Ki-1) antigen expression and histologic correlations. Am J Clin Pathol 93:698-702, 1990
31. Issacson PG, Schmid C, Pan L, et al: Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis. J Pathol 167:267-271, 1992
32. Henderson S, Rowe M, Gregory C, et al: Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107-1115, 1991
33. Schmid C, Pan L, Diss T, et al: Expression of B-cell antigens by Hodgkin's and Reed-Sternberg cells. Am J Pathol 139:701-707, 1991
34. Zutter M, Hockenbery D, Silverman GA, et al: Immunolocalization of the bcl-2 protein within hematopoietic neoplasms. Blood 78:1062-1068, 1991